Brian Bonnell - Mar 7, 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chief Financial Officer
Signature
By: Paula Darbyshire, Attorney-in-fact For: Brian Bonnell
Stock symbol
ICUI
Transactions as of
Mar 7, 2024
Transactions value $
-$1,412,330
Form type
4
Date filed
3/11/2024, 04:28 PM
Previous filing
May 18, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +2.15K +17.28% $0.00 14.6K Mar 7, 2024 Direct F1
transaction ICUI Common Stock Tax liability -$124K -1.18K -8.07% $105.39 13.4K Mar 7, 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +12.9K +96.17% $0.00 26.3K Mar 7, 2024 Direct F2
transaction ICUI Common Stock Tax liability -$744K -7.06K -26.88% $105.39 19.2K Mar 7, 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +2.21K +11.51% $0.00 21.4K Mar 8, 2024 Direct F1
transaction ICUI Common Stock Tax liability -$127K -1.21K -5.66% $104.52 20.2K Mar 8, 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +7.29K +36.09% $0.00 27.5K Mar 8, 2024 Direct F2
transaction ICUI Common Stock Tax liability -$418K -4K -14.55% $104.52 23.5K Mar 8, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -2.21K -100% $0.00* 0 Mar 8, 2024 Common Stock 2.21K $0.00 Direct F1, F3, F4, F5
transaction ICUI Common Stock Options Exercise $0 -2.15K -49.99% $0.00 2.15K Mar 7, 2024 Common Stock 2.15K $0.00 Direct F1, F3, F4, F5
transaction ICUI Performance Shares Options Exercise $0 -12.9K -100% $0.00* 0 Mar 7, 2024 Common Stock 12.9K $0.00 Direct F2, F6, F7
transaction ICUI Performance Shares Options Exercise $0 -7.29K -100% $0.00* 0 Mar 8, 2024 Common Stock 7.29K $0.00 Direct F2, F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 These Securities are Performance-based Restricted Stock Units (PRSU).
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These are restricted stock units that fully vest 3 years from the grant date.
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
F8 These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.